Pharmacokinetics study of the optimized abaloparatide transdermal patch (TD) in healthy postmenopausal women

Trial Profile

Pharmacokinetics study of the optimized abaloparatide transdermal patch (TD) in healthy postmenopausal women

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Sep 2016

At a glance

  • Drugs Abaloparatide (Primary) ; Abaloparatide
  • Indications Postmenopausal osteoporosis
  • Focus Pharmacokinetics
  • Sponsors Radius Health Inc.
  • Most Recent Events

    • 19 Sep 2016 Data from pilot pharmacokinetic studies will be to used to design a formal bioequivalence study, according to a Radius Health Inc media release.
    • 19 Sep 2016 Results from this trial presented at the American Society for Bone and Mineral Research (ASBMR) 2016 Annual Meeting, according to a Radius Health Inc media release.
    • 20 Jul 2016 Results will be presented at the American Society for Bone and Mineral Research (ASBMR) 2016 Annual Meeting, according to a Radius Health Inc media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top